Brazil to resume production of insulin

Rio de Janeiro, April 17 (IANS) Brazil will resume production of insulin on a large scale after 14 years of depending on imports, Health Minister Alexandre Padilha said.

“Today is a historic day. We are showing how important it is for a country of continental dimensions such as Brazil to have its own insulin production,” the minister said Tuesday.

The government will invest 430 million reais ($215 million) in the project over the next five years, mostly financed by the Brazilian Development Bank, Xinhua quoted Padilha as saying.

According to Padilha, a lab in southeastern Minas Gerais state will produce the drug.

The move is part of a government strategy to increase the country’s independence on drugs and medical equipment.

Since 2001, Brazil has depended on imports to provide a regular supply of insulin to diabetics as its insulin-producing lab had been sold to a foreign buyer.

“With the insulin being produced abroad, any strategic decision of a company can lead to insecurity in the insulin supply,” he said, adding it would be safer for Brazilian patients to depend on insulin domestically produced.

The minister said once operational, the new factory is expected to meet half of the needs of the 1.1 million patients, who depend exclusively on insulin distributed by the public healthcare system. Brazil has some 10 million diabetics.

The opinions, beliefs and viewpoints expressed by authors, news service providers on this page do not necessarily reflect the opinions, beliefs and viewpoints of Hill Post. Any views or opinions are not intended to malign any religion, ethnic group, club, organization, company, or individual. Hill Post makes no representations as to the accuracy or completeness of any information on this site page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.